0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Screening Tests Market Size, Status and Forecast 2021-2027
Published Date: June 2021
|
Report Code: QYRE-Auto-12V5380
Home | Market Reports | Health | Medical Facilities & Services | Medical Procedures
Global Cancer Screening Tests Market Size Status and Forecast 2021 2027

Global Cancer Screening Tests Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-12V5380
Report
June 2021
118 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Global Cancer Screening Tests Scope and Market Size
Cancer Screening Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Screening Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Physical Exam
Imaging Tests
Genetic Tests
Other

Segment by Application

Hospital
Clinic
Lab
Other

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Hologic
Siemens
GRAIL
Carestream Health
Philips
Shimadzu
Canon Medical Systems
Hitachi
Esaote
Agilent Technologies
Abbott
Beckman Coulter
QIAGEN
R-Biopharm
Sysmex
Thrive Early Early Detection
Guardant Health
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Tests Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Physical Exam
1.2.3 Imaging Tests
1.2.4 Genetic Tests
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Screening Tests Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Tests Market Perspective (2016-2027)
2.2 Cancer Screening Tests Growth Trends by Regions
2.2.1 Cancer Screening Tests Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Screening Tests Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Screening Tests Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Screening Tests Industry Dynamic
2.3.1 Cancer Screening Tests Market Trends
2.3.2 Cancer Screening Tests Market Drivers
2.3.3 Cancer Screening Tests Market Challenges
2.3.4 Cancer Screening Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Tests Players by Revenue
3.1.1 Global Top Cancer Screening Tests Players by Revenue (2016-2021)
3.1.2 Global Cancer Screening Tests Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Screening Tests Revenue
3.4 Global Cancer Screening Tests Market Concentration Ratio
3.4.1 Global Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Tests Revenue in 2020
3.5 Cancer Screening Tests Key Players Head office and Area Served
3.6 Key Players Cancer Screening Tests Product Solution and Service
3.7 Date of Enter into Cancer Screening Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Tests Breakdown Data by Type
4.1 Global Cancer Screening Tests Historic Market Size by Type (2016-2021)
4.2 Global Cancer Screening Tests Forecasted Market Size by Type (2022-2027)
5 Cancer Screening Tests Breakdown Data by Application
5.1 Global Cancer Screening Tests Historic Market Size by Application (2016-2021)
5.2 Global Cancer Screening Tests Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Screening Tests Market Size (2016-2027)
6.2 North America Cancer Screening Tests Market Size by Type
6.2.1 North America Cancer Screening Tests Market Size by Type (2016-2021)
6.2.2 North America Cancer Screening Tests Market Size by Type (2022-2027)
6.2.3 North America Cancer Screening Tests Market Size by Type (2016-2027)
6.3 North America Cancer Screening Tests Market Size by Application
6.3.1 North America Cancer Screening Tests Market Size by Application (2016-2021)
6.3.2 North America Cancer Screening Tests Market Size by Application (2022-2027)
6.3.3 North America Cancer Screening Tests Market Size by Application (2016-2027)
6.4 North America Cancer Screening Tests Market Size by Country
6.4.1 North America Cancer Screening Tests Market Size by Country (2016-2021)
6.4.2 North America Cancer Screening Tests Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Screening Tests Market Size (2016-2027)
7.2 Europe Cancer Screening Tests Market Size by Type
7.2.1 Europe Cancer Screening Tests Market Size by Type (2016-2021)
7.2.2 Europe Cancer Screening Tests Market Size by Type (2022-2027)
7.2.3 Europe Cancer Screening Tests Market Size by Type (2016-2027)
7.3 Europe Cancer Screening Tests Market Size by Application
7.3.1 Europe Cancer Screening Tests Market Size by Application (2016-2021)
7.3.2 Europe Cancer Screening Tests Market Size by Application (2022-2027)
7.3.3 Europe Cancer Screening Tests Market Size by Application (2016-2027)
7.4 Europe Cancer Screening Tests Market Size by Country
7.4.1 Europe Cancer Screening Tests Market Size by Country (2016-2021)
7.4.2 Europe Cancer Screening Tests Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Tests Market Size (2016-2027)
8.2 Asia-Pacific Cancer Screening Tests Market Size by Type
8.2.1 Asia-Pacific Cancer Screening Tests Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Screening Tests Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Screening Tests Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Screening Tests Market Size by Application
8.3.1 Asia-Pacific Cancer Screening Tests Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Screening Tests Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Screening Tests Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Screening Tests Market Size by Region
8.4.1 Asia-Pacific Cancer Screening Tests Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Screening Tests Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Screening Tests Market Size (2016-2027)
9.2 Latin America Cancer Screening Tests Market Size by Type
9.2.1 Latin America Cancer Screening Tests Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Screening Tests Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Screening Tests Market Size by Type (2016-2027)
9.3 Latin America Cancer Screening Tests Market Size by Application
9.3.1 Latin America Cancer Screening Tests Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Screening Tests Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Screening Tests Market Size by Application (2016-2027)
9.4 Latin America Cancer Screening Tests Market Size by Country
9.4.1 Latin America Cancer Screening Tests Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Screening Tests Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Tests Market Size (2016-2027)
10.2 Middle East & Africa Cancer Screening Tests Market Size by Type
10.2.1 Middle East & Africa Cancer Screening Tests Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Screening Tests Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Screening Tests Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Screening Tests Market Size by Application
10.3.1 Middle East & Africa Cancer Screening Tests Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Screening Tests Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Screening Tests Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Screening Tests Market Size by Country
10.4.1 Middle East & Africa Cancer Screening Tests Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Screening Tests Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Details
11.1.2 Hologic Business Overview
11.1.3 Hologic Cancer Screening Tests Introduction
11.1.4 Hologic Revenue in Cancer Screening Tests Business (2016-2021)
11.1.5 Hologic Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Cancer Screening Tests Introduction
11.2.4 Siemens Revenue in Cancer Screening Tests Business (2016-2021)
11.2.5 Siemens Recent Development
11.3 GRAIL
11.3.1 GRAIL Company Details
11.3.2 GRAIL Business Overview
11.3.3 GRAIL Cancer Screening Tests Introduction
11.3.4 GRAIL Revenue in Cancer Screening Tests Business (2016-2021)
11.3.5 GRAIL Recent Development
11.4 Carestream Health
11.4.1 Carestream Health Company Details
11.4.2 Carestream Health Business Overview
11.4.3 Carestream Health Cancer Screening Tests Introduction
11.4.4 Carestream Health Revenue in Cancer Screening Tests Business (2016-2021)
11.4.5 Carestream Health Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips Cancer Screening Tests Introduction
11.5.4 Philips Revenue in Cancer Screening Tests Business (2016-2021)
11.5.5 Philips Recent Development
11.6 Shimadzu
11.6.1 Shimadzu Company Details
11.6.2 Shimadzu Business Overview
11.6.3 Shimadzu Cancer Screening Tests Introduction
11.6.4 Shimadzu Revenue in Cancer Screening Tests Business (2016-2021)
11.6.5 Shimadzu Recent Development
11.7 Canon Medical Systems
11.7.1 Canon Medical Systems Company Details
11.7.2 Canon Medical Systems Business Overview
11.7.3 Canon Medical Systems Cancer Screening Tests Introduction
11.7.4 Canon Medical Systems Revenue in Cancer Screening Tests Business (2016-2021)
11.7.5 Canon Medical Systems Recent Development
11.8 Hitachi
11.8.1 Hitachi Company Details
11.8.2 Hitachi Business Overview
11.8.3 Hitachi Cancer Screening Tests Introduction
11.8.4 Hitachi Revenue in Cancer Screening Tests Business (2016-2021)
11.8.5 Hitachi Recent Development
11.9 Esaote
11.9.1 Esaote Company Details
11.9.2 Esaote Business Overview
11.9.3 Esaote Cancer Screening Tests Introduction
11.9.4 Esaote Revenue in Cancer Screening Tests Business (2016-2021)
11.9.5 Esaote Recent Development
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Cancer Screening Tests Introduction
11.10.4 Agilent Technologies Revenue in Cancer Screening Tests Business (2016-2021)
11.10.5 Agilent Technologies Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Cancer Screening Tests Introduction
11.11.4 Abbott Revenue in Cancer Screening Tests Business (2016-2021)
11.11.5 Abbott Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Details
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Cancer Screening Tests Introduction
11.12.4 Beckman Coulter Revenue in Cancer Screening Tests Business (2016-2021)
11.12.5 Beckman Coulter Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Tests Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Tests Business (2016-2021)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Details
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Tests Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Tests Business (2016-2021)
11.14.5 R-Biopharm Recent Development
11.15 Sysmex
11.15.1 Sysmex Company Details
11.15.2 Sysmex Business Overview
11.15.3 Sysmex Cancer Screening Tests Introduction
11.15.4 Sysmex Revenue in Cancer Screening Tests Business (2016-2021)
11.15.5 Sysmex Recent Development
11.16 Thrive Early Early Detection
11.16.1 Thrive Early Early Detection Company Details
11.16.2 Thrive Early Early Detection Business Overview
11.16.3 Thrive Early Early Detection Cancer Screening Tests Introduction
11.16.4 Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2016-2021)
11.16.5 Thrive Early Early Detection Recent Development
11.17 Guardant Health
11.17.1 Guardant Health Company Details
11.17.2 Guardant Health Business Overview
11.17.3 Guardant Health Cancer Screening Tests Introduction
11.17.4 Guardant Health Revenue in Cancer Screening Tests Business (2016-2021)
11.17.5 Guardant Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Cancer Screening Tests Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Physical Exam
    Table 3. Key Players of Imaging Tests
    Table 4. Key Players of Genetic Tests
    Table 5. Key Players of Other
    Table 6. Global Cancer Screening Tests Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Cancer Screening Tests Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Cancer Screening Tests Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Cancer Screening Tests Market Share by Regions (2016-2021)
    Table 10. Global Cancer Screening Tests Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Cancer Screening Tests Market Share by Regions (2022-2027)
    Table 12. Cancer Screening Tests Market Trends
    Table 13. Cancer Screening Tests Market Drivers
    Table 14. Cancer Screening Tests Market Challenges
    Table 15. Cancer Screening Tests Market Restraints
    Table 16. Global Cancer Screening Tests Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Cancer Screening Tests Market Share by Players (2016-2021)
    Table 18. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Screening Tests as of 2020)
    Table 19. Ranking of Global Top Cancer Screening Tests Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Cancer Screening Tests Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cancer Screening Tests Product Solution and Service
    Table 23. Date of Enter into Cancer Screening Tests Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Cancer Screening Tests Revenue Market Share by Type (2016-2021)
    Table 27. Global Cancer Screening Tests Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Cancer Screening Tests Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Cancer Screening Tests Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Cancer Screening Tests Revenue Market Share by Application (2016-2021)
    Table 31. Global Cancer Screening Tests Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Cancer Screening Tests Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Cancer Screening Tests Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Cancer Screening Tests Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Cancer Screening Tests Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Cancer Screening Tests Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Cancer Screening Tests Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Cancer Screening Tests Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Cancer Screening Tests Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Cancer Screening Tests Market Size by Country (2022-2027) & (US$ Million)
    Table 63. Hologic Company Details
    Table 64. Hologic Business Overview
    Table 65. Hologic Cancer Screening Tests Product
    Table 66. Hologic Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 67. Hologic Recent Development
    Table 68. Siemens Company Details
    Table 69. Siemens Business Overview
    Table 70. Siemens Cancer Screening Tests Product
    Table 71. Siemens Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 72. Siemens Recent Development
    Table 73. GRAIL Company Details
    Table 74. GRAIL Business Overview
    Table 75. GRAIL Cancer Screening Tests Product
    Table 76. GRAIL Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 77. GRAIL Recent Development
    Table 78. Carestream Health Company Details
    Table 79. Carestream Health Business Overview
    Table 80. Carestream Health Cancer Screening Tests Product
    Table 81. Carestream Health Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 82. Carestream Health Recent Development
    Table 83. Philips Company Details
    Table 84. Philips Business Overview
    Table 85. Philips Cancer Screening Tests Product
    Table 86. Philips Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 87. Philips Recent Development
    Table 88. Shimadzu Company Details
    Table 89. Shimadzu Business Overview
    Table 90. Shimadzu Cancer Screening Tests Product
    Table 91. Shimadzu Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 92. Shimadzu Recent Development
    Table 93. Canon Medical Systems Company Details
    Table 94. Canon Medical Systems Business Overview
    Table 95. Canon Medical Systems Cancer Screening Tests Product
    Table 96. Canon Medical Systems Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 97. Canon Medical Systems Recent Development
    Table 98. Hitachi Company Details
    Table 99. Hitachi Business Overview
    Table 100. Hitachi Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 101. Hitachi Recent Development
    Table 102. Esaote Company Details
    Table 103. Esaote Business Overview
    Table 104. Esaote Cancer Screening Tests Product
    Table 105. Esaote Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 106. Esaote Recent Development
    Table 107. Agilent Technologies Company Details
    Table 108. Agilent Technologies Business Overview
    Table 109. Agilent Technologies Cancer Screening Tests Product
    Table 110. Agilent Technologies Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 111. Agilent Technologies Recent Development
    Table 112. Abbott Company Details
    Table 113. Abbott Business Overview
    Table 114. Abbott Cancer Screening Tests Product
    Table 115. Abbott Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 116. Abbott Recent Development
    Table 117. Beckman Coulter Company Details
    Table 118. Beckman Coulter Business Overview
    Table 119. Beckman Coulter Cancer Screening Tests Product
    Table 120. Beckman Coulter Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 121. Beckman Coulter Recent Development
    Table 122. QIAGEN Company Details
    Table 123. QIAGEN Business Overview
    Table 124. QIAGEN Cancer Screening Tests Product
    Table 125. QIAGEN Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 126. QIAGEN Recent Development
    Table 127. R-Biopharm Company Details
    Table 128. R-Biopharm Business Overview
    Table 129. R-Biopharm Cancer Screening Tests Product
    Table 130. R-Biopharm Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 131. R-Biopharm Recent Development
    Table 132. Sysmex Company Details
    Table 133. Sysmex Business Overview
    Table 134. Sysmex Cancer Screening Tests Product
    Table 135. Sysmex Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 136. Sysmex Recent Development
    Table 137. Thrive Early Early Detection Company Details
    Table 138. Thrive Early Early Detection Business Overview
    Table 139. Thrive Early Early Detection Cancer Screening Tests Product
    Table 140. Thrive Early Early Detection Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 141. Thrive Early Early Detection Recent Development
    Table 142. Guardant Health Company Details
    Table 143. Guardant Health Business Overview
    Table 144. Guardant Health Cancer Screening Tests Product
    Table 145. Guardant Health Revenue in Cancer Screening Tests Business (2016-2021) & (US$ Million)
    Table 146. Guardant Health Recent Development
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Screening Tests Market Share by Type: 2020 VS 2027
    Figure 2. Physical Exam Features
    Figure 3. Imaging Tests Features
    Figure 4. Genetic Tests Features
    Figure 5. Other Features
    Figure 6. Global Cancer Screening Tests Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Lab Case Studies
    Figure 10. Other Case Studies
    Figure 11. Cancer Screening Tests Report Years Considered
    Figure 12. Global Cancer Screening Tests Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Cancer Screening Tests Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Cancer Screening Tests Market Share by Regions: 2020 VS 2027
    Figure 15. Global Cancer Screening Tests Market Share by Regions (2022-2027)
    Figure 16. Global Cancer Screening Tests Market Share by Players in 2020
    Figure 17. Global Top Cancer Screening Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Screening Tests as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Cancer Screening Tests Revenue in 2020
    Figure 19. Global Cancer Screening Tests Revenue Market Share by Type (2016-2021)
    Figure 20. Global Cancer Screening Tests Revenue Market Share by Type (2022-2027)
    Figure 21. North America Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Cancer Screening Tests Market Share by Type (2016-2027)
    Figure 23. North America Cancer Screening Tests Market Share by Application (2016-2027)
    Figure 24. North America Cancer Screening Tests Market Share by Country (2016-2027)
    Figure 25. United States Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Cancer Screening Tests Market Share by Type (2016-2027)
    Figure 29. Europe Cancer Screening Tests Market Share by Application (2016-2027)
    Figure 30. Europe Cancer Screening Tests Market Share by Country (2016-2027)
    Figure 31. Germany Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Cancer Screening Tests Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Cancer Screening Tests Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Cancer Screening Tests Market Share by Region (2016-2027)
    Figure 41. China Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Cancer Screening Tests Market Share by Type (2016-2027)
    Figure 49. Latin America Cancer Screening Tests Market Share by Application (2016-2027)
    Figure 50. Latin America Cancer Screening Tests Market Share by Country (2016-2027)
    Figure 51. Mexico Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Cancer Screening Tests Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Cancer Screening Tests Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Cancer Screening Tests Market Share by Country (2016-2027)
    Figure 57. Turkey Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Cancer Screening Tests Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Hologic Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 61. Siemens Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 62. GRAIL Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 63. Carestream Health Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 64. Philips Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 65. Shimadzu Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 66. Canon Medical Systems Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 67. Hitachi Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 68. Esaote Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 69. Agilent Technologies Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 70. Abbott Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 71. Beckman Coulter Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 72. QIAGEN Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 73. R-Biopharm Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 74. Sysmex Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 75. Thrive Early Early Detection Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 76. Guardant Health Revenue Growth Rate in Cancer Screening Tests Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Infectious Disease Diagnosis Market Size Status and Forecast 2021 2027
Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10N1843
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Stoma or Ostomy Care Market Size Status and Forecast 2021 2027
Global Stoma or Ostomy Care Market Size, Status and Forecast 2021-2027

There are different types of ostomy operations such as colostomy ileostomy and urostomy which are performed depending on the requirement of the disease and the patient.Market Analysis and Insights Global Stoma or Ostomy Care MarketThe global Stoma or Ostomy Care market size is projected to reach US 1116 million by 2027 from US 817.9 million in 2020 at a CAGR of 4.1 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Stoma or Ostomy Care market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-19X2808
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Prothrombin Time Testing Market Size Status and Forecast 2021 2027
Global Prothrombin Time Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18O2842
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Cystatin C Testing Market Size Status and Forecast 2021 2027
Global Cystatin C Testing Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-5Q1261
Sun Jul 18 00:00:00 UTC 2021

Add to Cart